+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodeoxycholic acid and methotrexate for primary sclerosing cholangitis A pilot study



Ursodeoxycholic acid and methotrexate for primary sclerosing cholangitis A pilot study



Hepatology 20(4 Part 2): 148A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144796

Download citation: RISBibTeXText


Related references

Ursodeoxycholic acid and methotrexate for primary sclerosing cholangitis: a pilot study. American Journal of Gastroenterology 91(3): 511-515, 1996

Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study. Hepatology 14(5): 838-847, 1991

Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group. New England Journal of Medicine 336(10): 691-695, 1997

Combination Therapy of All-Trans Retinoic Acid With Ursodeoxycholic Acid in Patients With Primary Sclerosing Cholangitis: A Human Pilot Study. Journal of Clinical Gastroenterology 51(2): E11-E16, 2016

Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: A randomized double-blind pilot study. American Journal of Gastroenterology 95(8): 2015-2022, 2000

Treatment with budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis A randomized controlled pilot study. Hepatology 28(4 Part 2): 647A, 1998

A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis. Alimentary Pharmacology and Therapeutics 20(9): 943-949, 2004

Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period. Journal of Hepatology 20(1): 57-64, 1994

The effect of ursodeoxycholic treatment in primary sclerosing cholangitis Results of a pilot study. Gastroenterology 104(4 Suppl. ): A966, 1993

Treatment of primary sclerosing cholangitis with ursodeoxycholic acid first results of a controlled study. Hepatology 10(4): 602, 1989

Treatment of primary sclerosing cholangitis with the combination of ursodiol, methotrexate and rotating antibiotics A pilot study. Hepatology 28(4 Part 2): 189A, 1998

Ursodeoxycholic acid for chemoprevention in ulcerative colitis and primary sclerosing cholangitis A retrospective cohort Study. American Journal of Gastroenterology 98(9 Suppl.): S258, 2003

Ursodeoxycholic acid for chemoprevention in ulcerative colitis and primary sclerosing cholangitis: a retrospectove cohort study. American Journal of Gastroenterology 98: S258-S258, 2003

High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study. Gastroenterology 129(5): 1464-1472, 2005

Ursodeoxycholic acid in primary sclerosing cholangitis. Alimentary Pharmacology and Therapeutics 35(5): 622-623, 2012